Synergistic effects of topical diphencyprone and immune checkpoint inhibition in treating cutaneous metastases

被引：0
|
作者：
Block, B. R. [1 ]
Piontkowski, A. [1 ]
Poplausky, D. [1 ]
Estrada, Y. [1 ]
Gour, D. [1 ]
Gulati, N. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dermatol, New York, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2024年 / 144卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
294
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [1] Definite regression of cutaneous melanoma metastases upon addition of topical contact sensitizer diphencyprone to immune checkpoint inhibitor treatment
    Gulati, Nicholas
    Carvajal, Richard D.
    Postow, Michael A.
    Wolchok, Jedd D.
    Krueger, James G.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 (07) : 553 - 554
  • [2] Topical diphencyprone induces immune activation and anti-tumor effects in cutaneous neurofibromas
    Orloff, J.
    Seah, C.
    Poplausky, D.
    Block, B. R.
    Rivera-Oyola, R.
    Piontkowski, A.
    Powers, C. M.
    Young, J. N.
    Bose, S.
    Estrada, Y.
    Da Rosa, J. Correa
    Guttman-Yassky, E.
    Brown, R. M.
    Gulati, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S49 - S49
  • [3] Proteomic profiling of a patient with cutaneous melanoma metastasis regression following topical contact sensitizer diphencyprone and immune checkpoint inhibitor treatment
    Joseph Han
    Aneesh Agarwal
    Jade N. Young
    Shayan Owji
    Yen Luu
    Dina Poplausky
    Daniel Yassky
    Yeriel Estrada
    Jonathan Ungar
    James G. Krueger
    Nicholas Gulati
    Scientific Reports, 12
  • [4] Immunomodulatory effects of topical diphencyprone for the treatment of acute urban cutaneous leishmaniasis
    Nahidi, Yalda
    Goyonlo, Vahid Mashayekhi
    Layegh, Pouran
    Taghavi, Faezeh
    Najafi, Mona Najaf
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (02) : 220 - 226
  • [5] Proteomic profiling of a patient with cutaneous melanoma metastasis regression following topical contact sensitizer diphencyprone and immune checkpoint inhibitor treatment
    Han, Joseph
    Agarwal, Aneesh
    Young, Jade N.
    Owji, Shayan
    Luu, Yen
    Poplausky, Dina
    Yassky, Daniel
    Estrada, Yeriel
    Ungar, Jonathan
    Krueger, James G.
    Gulati, Nicholas
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] Immune checkpoint inhibition in patients with brain metastases
    Johanns, Tanner
    Waqar, Saiama N.
    Morgensztern, Daniel
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4
  • [7] Efficacy of immune checkpoint inhibitors for treating uveal melanoma metastases
    Oxenreiter, Monica
    Lane, Anne Marie
    Cohen, Justine V.
    Sullivan, Ryan J.
    Kim, Ivana K.
    Gragoudas, Evangelos S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [8] Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma
    Mochel, Mark C.
    Ming, Michael E.
    Imadojemu, Sotonye
    Gangadhar, Tara C.
    Schuchter, Lynn M.
    Elenitsas, Rosalie
    Payne, Aimee S.
    Chu, Emily Y.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2016, 43 (09) : 787 - 791
  • [9] Case report: Regression of in-transit metastases of cutaneous squamous cell carcinoma with combination pembrolizumab and topical diphencyprone
    Poplausky, Dina
    Young, Jade N.
    Block, Brandon R.
    Estrada, Yeriel
    Singer, Giselle K.
    Wong, Vicky
    Cabral, Patricia
    Suemitsu, Yamato
    Kim, Randie H.
    Friedlander, Philip
    Gulati, Nicholas
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [10] Cutaneous adverse effects of the immune checkpoint inhibitors
    Collins, Lindsey K.
    Chapman, M. Shane
    Carter, Joi B.
    Samie, Faramarz H.
    CURRENT PROBLEMS IN CANCER, 2017, 41 (02) : 125 - 128
12345